Management of Acute Liver Failure: Update 2022.
Tujios S, Stravitz RT, Lee WM.
Semin Liver Dis. 2022 Aug;42(3):362-378. doi: 10.1055/s-0042-1755274. Epub 2022 Aug 24.
Kidney Dysfunction in the Setting of Liver Failure: Core Curriculum 2024.
Kanduri SR, Velez JCQ.
Am J Kidney Dis. 2024 Mar;83(3):386-401. doi: 10.1053/j.ajkd.2023.08.013. Epub 2023 Dec 7.
Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis.
Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman R, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure.
J Clin Exp Hepatol. 2020 Jul-Aug;10(4):339-376. doi: 10.1016/j.jceh.2020.04.012. Epub 2020 Apr 28.
Gestational alloimmune liver disease and neonatal hemochromatosis.
Whitington PF.
Semin Liver Dis. 2012 Nov;32(4):325-32. doi: 10.1055/s-0032-1329901. Epub 2013 Feb 8.
Risk factors and prognostic model for HBV-related subacute liver failure.
Xu J, Du F, Yang N, Hou J, Fan Y, Liu X.
Ann Transl Med. 2022 Apr;10(7):406. doi: 10.21037/atm-22-461.
Liver transplantation for subacute hepatic necrosis and rapid liver failure following bariatric surgery.
Aliseda D, Cienfuegos JA, Valenti V, Echeveste JI, Lujan J, Almeida A, Rotellar F.
ANZ J Surg. 2022 Mar;92(3):620. doi: 10.1111/ans.17373.
Subacute liver failure.
Shah SC, Shah SR, Amarapurkar DN.
Lancet. 1993 Oct 30;342(8879):1119. doi: 10.1016/0140-6736(93)92105-3.
Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation.
Tadokoro T, Murata S, Kato M, Ueno Y, Tsuchida T, Okumura A, Kuse Y, Konno T, Uchida Y, Yamakawa Y, Zushi M, Yajima M, Kobayashi T, Hasegawa S, Kawakatsu-Hatada Y, Hayashi Y, Osakabe S, Maeda T, Kimura K, Mori A, Tanaka M, Kamishibahara Y, Matsuo M, Nie YZ, Okamoto S, Oba T, Tanimizu N, Taniguchi H.
Sci Transl Med. 2024 Jul 24;16(757):eadg0338. doi: 10.1126/scitranslmed.adg0338. Epub 2024 Jul 24.
A mouse model of subacute liver failure with ascites induced by step-wise increased doses of (-)-epigallocatechin-3-gallate.
Wang X, Yang L, Wang J, Zhang Y, Dong R, Wu X, Yang CS, Zhang Z, Zhang J.
Sci Rep. 2019 Dec 2;9(1):18102. doi: 10.1038/s41598-019-54691-0.
Immune mediated liver failure.
Wang X, Ning Q.
EXCLI J. 2014 Oct 1;13:1131-44. eCollection 2014.
